STEINMAN LAWRENCE - 01 Jun 2023 Form 4 Insider Report for 180 Life Sciences Corp. (ATNF)

Role: Director
Signature: /s/ Lawrence Steinman, M.D.
Issuer symbol: ATNF
Transactions as of: 01 Jun 2023
Net transactions value: +$22,068
Form type: 4
Filing time: 02 Jun 2023, 08:00:18 UTC
Previous filing: 28 Nov 2022
Next filing: 06 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ATNF	Common Stock	Purchase	$22,068	+18,000	+60%	$1.23	48,129	01 Jun 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was executed in multiple trades at prices ranging from $1.15 to $1.26. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Content

This transaction was executed in multiple trades at prices ranging from $1.15 to $1.26. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.